Yuhan, Boehringer Ingelheim Korea to co-market Twynsta in Korea

Published: 2010-10-07 06:58:00
Updated: 2010-10-07 06:58:00
Yuhan Corp. and Boehringer Ingelheim Korea announced on October 5 that the two companies have signed an agreement to co-market Twynsta (telmisartan/amlodipine) in Korea.

The domestic hypertension market is estimated at 1.4 trillion won. The medicine has been available from November 2009 in th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.